Worth reading
90Important
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of new shares and the Third Series Stock Acquisition Rights through a third-party allotment
Specific use of funds
Working capitalAmount ¥77 million / Scheduled timing of expenditures June 2026 to July 2026
Regional revitalization and healthcare-related businessAmount ¥25 million / Scheduled timing of expenditures June 2026 to March 2027
Most recent equity financing
Issuance of new shares and the 3rd stock acquisition rights through a third-party allotment dated 9 June 2026
Impact on Business Performance
The impact on results for the fiscal year ending March 2027 is expected to be immaterial, but as it may affect the company's results in the future, timely disclosures will be made regarding progress going forward.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares and the Third Series Stock Acquisition Rights through a third-party allotment |
| Specific use of funds | Details Working capital / Amount ¥77 million / Scheduled timing of expenditures June 2026 to July 2026, Details Regional revitalization and healthcare-related business / Amount ¥25 million / Scheduled timing of expenditures June 2026 to March 2027 |
| Most recent equity financing | Issuance of new shares and the 3rd stock acquisition rights through a third-party allotment dated 9 June 2026 |
| Impact on Business Performance | The impact on results for the fiscal year ending March 2027 is expected to be immaterial, but as it may affect the company's results in the future, timely disclosures will be made regarding progress going forward. |
Items this document does not state (24)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To establish a more efficient and agile operating structure for each business, it was decided that the business would be pursued by an operating company dedicated to the business rather than under a concurrent-role structure. The timing of fund expenditures was also reviewed in light of the current progress of the business.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.